Evaluation of the Decision-making During Multidisciplinary Meetings for Digestive Cancers

Decision Making Clinical Trial

Official title:

Prospective Evaluation of the Decision-making During Multidisciplinary Meetings for Digestive Cancers

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04000802
• Other study ID #: MODE_INO
• Status: Completed
• Start date: May 23, 2019
• Est. completion date: September 1, 2019

Study information

• Verified date: October 2019
• Source: Moroccan Society of Surgery
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Nowadays, the recommended approach for decision-making for oncology patients is based on multidisciplinary meetings (MDT). However, the quality of decision-making during MDT depends on other factors such as the quality of presentation of clinical cases, the degree of participation of different specialists.

In this study, the investigators will evaluate the decision-making during digestive oncology MDT using the validated "Metric Of Decision-Making" tool (MDT-MODe), in the national institute of oncology (Rabat, Morocco).

Description:

Multidisciplinary cancer meetings are a multidisciplinary discussion and decision-making process for a patient with cancer. It allows a sharing of knowledge and decision-making, taking into account the opinion of all the specialists involved in the treatment of cancer, in order to propose the best possible decision for the patient. Nevertheless, the quality of decision-making during CPR depends on other factors such as the quality of presentation of clinical cases, the degree of participation of different specialists and the dynamics of meetings.

There are several validated tools for the quantitative assessment of the decision-making mode during CPRs. The best known is the Metric Of Decision-Making (MDT-MODe). MDT-MODe is a validated tool for the observational evaluation of teamwork and the quality of decision-making during cancer CPR.

MDT-MODe is designed to encourage teams to make holistic decisions tailored to each patient and allows an observer to assess, on a case-by-case basis, in a quantitative and objective way:

The quality of the clinical information (antecedents, radiological pathologies, pathological, comorbid, psychosocial problems and patients' points of view) Contribution to decision-making in teams of key professional groups (surgeons, physicians, oncologists, nurses, health professionals, radiologists, pathologists) Taken together, these notes provide an indication of the quality of team decision-making.

In this study, the investigators will evaluate the decision-making during digestive oncology MDT using the validated "Metric Of Decision-Making" tool (MDT-MODe), in the national institute of oncology (Rabat, Morocco).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: September 1, 2019
• Est. primary completion date: July 4, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• All consecutive cases presented during multidisciplinary cancer meeting for digestive cancer.

Exclusion Criteria:

• Cases not registered in the electronic health record system.

Related Conditions & MeSH terms

• Decision Making
• Neoplasms/Therapy
• Patient Care Team
• Quality of Health Care

Intervention

Behavioral:
• response to questionnary
No intervention. Observational study

Locations

Country	Name	City	State
Morocco	National Institut of oncology	Rabat

Sponsors (1)

Lead Sponsor	Collaborator
Moroccan Society of Surgery

Country where clinical trial is conducted

Morocco, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	MODE-MDT scores	The scores of the Metric Of Decision-Making tool during multidisciplinary team meeting for digestive cancer. The instrument include 10 questions rated from 1 to 5. Higher scores indicate better results. The instrument include questions about the quality of clinical information (History, radiological, pathological, comorbid health conditions, psychosocial issues, and patients' views) and the contribution to team decision making of key professional groups (Surgeons, physicians, oncologists, nurses, allied healthcare professionals, radiologists, pathologists and MDT coordinators) ans a question about the decision (Clear, deferred, no decision. Each question is analyzed separately (mean, median, standard deviation, quartiles).	60 days from the multidisciplinary team meeting
Secondary	Decision reached	The rate of cases with decisions during multidisciplinary team meetings (Clear decision about treatment in the MODE-MDT instrument).	60 days from the multidisciplinary team meeting
Secondary	Decision factors	Predictive factors for reaching a clear decision about treatment during multidisciplinary team meetings. The factors analyzed are the question of the MODE-MDT instrument.	60 days from the multidisciplinary team meeting